The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validation of the NSABP neoadjuvant rectal score (NAR) in a prospective phase II study evaluating an experimental regimen and a standard chemoradiation cohort with molecular genotyping.
Theodore S. Hong
No relevant relationships to disclose
Jackie Szymonifka
No relevant relationships to disclose
Greg Yothers
No relevant relationships to disclose
Lawrence Scott Blaszkowsky
No relevant relationships to disclose
Andrea Lyn Russo
No relevant relationships to disclose
Jennifer Yon-Li Wo
No relevant relationships to disclose
Harvey J. Mamon
No relevant relationships to disclose
Eunice Lee Kwak
No relevant relationships to disclose
Andrew X. Zhu
No relevant relationships to disclose
Jill N. Allen
No relevant relationships to disclose
Jeffrey W. Clark
No relevant relationships to disclose
David P. Ryan
No relevant relationships to disclose